BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33539852)

  • 21. Topical liposomal system for localized and controlled drug delivery.
    Singh R; Vyas SP
    J Dermatol Sci; 1996 Nov; 13(2):107-11. PubMed ID: 8953409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanocarriers For Vaginal Drug Delivery.
    Iqbal Z; Dilnawaz F
    Recent Pat Drug Deliv Formul; 2019; 13(1):3-15. PubMed ID: 30767755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery].
    Liu Y; Lü WL; Zhang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes as nanovaccine delivery systems.
    Ghaffar KA; Giddam AK; Zaman M; Skwarczynski M; Toth I
    Curr Top Med Chem; 2014; 14(9):1194-208. PubMed ID: 24678703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.
    Lai WF; Wong WT; Rogach AL
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43341-43351. PubMed ID: 32877163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical appraisal of microemulsions for drug delivery: part II.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary AK
    Ther Deliv; 2014 Jan; 5(1):83-94. PubMed ID: 24341819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of Liposomes for Enhancement of Oral Drug Absorption.
    Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
    Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modified release intra-articular drug delivery systems].
    Szabó A; Szabó B; Balogh E; Zelkó R; Antal I
    Acta Pharm Hung; 2012; 82(2):69-74. PubMed ID: 22870779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
    Slomkowski S; Gosecki M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy.
    Franco MS; Oliveira MC
    Biomed Pharmacother; 2017 Dec; 96():584-595. PubMed ID: 29035823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring novel approaches to vaginal drug delivery.
    Gupta S; Gabrani R; Ali J; Dang S
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):82-94. PubMed ID: 21413924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes in topical ophthalmic drug delivery: an update.
    Agarwal R; Iezhitsa I; Agarwal P; Abdul Nasir NA; Razali N; Alyautdin R; Ismail NM
    Drug Deliv; 2016 May; 23(4):1075-91. PubMed ID: 25116511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS-delivery via conjugation to biological carriers: physiological-based approaches.
    Vyas SP
    Prog Drug Res; 2003; 61():189-219. PubMed ID: 14674613
    [No Abstract]   [Full Text] [Related]  

  • 38. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral drug delivery with nanoparticulate carriers.
    Holback H; Yeo Y
    Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.